41 - 50 out of 52Page size: 10
  1. 2019

  2. Establishment of primary human breast cancer cell lines using "pulsed hypoxia" method and development of metastatic tumor model in immunodeficient mice

    Nushtaeva, A. A., Karpushina, A. A., Ermakov, M. S., Gulyaeva, L. F., Gerasimov, A. V., Sidorov, S. V., Gayner, T. A., Yunusova, A. Y., Tkachenko, A. V., Richter, V. A. & Koval, O. A., 28 Feb 2019, In: Cancer Cell International. 19, 1, p. 46 19 p., 46.

    Research output: Contribution to journal › Article › peer-review

  3. Boosting of the cytotoxic effect of RNAs by using the pro-apoptotic protein lactaptin for delivery of nucleic acids into cancer cells

    Golubitskaya, E., Chinak, O., Pyshnaya, I. A., Stepanov, G., Juravlev, E., Richter, K. & Koval, O., 3 Jan 2019, In: Cell Death Discovery. 5, 2 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  4. Implication of immune system in Vaccinia virus-induced cell death

    Koval, O., Kochneva, G., Troitskaya, O., Tkachenko, A., Nushtaeva, A., Kuligina, E. & Richter, V., 3 Jan 2019, In: Cell Death Discovery. 5, 2 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  5. 2018

  6. Characterization of primary normal and malignant breast cancer cell and their response to chemotherapy and immunostimulatory agents

    Nushtaeva, A. A., Stepanov, G. A., Semenov, D. V., Juravlev, E. S., Balahonova, E. A., Gerasimov, A. V., Sidorov, S. V., Savelyev, E. I., Kuligina, E. V., Richter, V. A. & Koval, O. A., 9 Jul 2018, In: BMC Cancer. 18, 1, p. 728 11 p., 728.

    Research output: Contribution to journal › Article › peer-review

  7. Induction of the immunogenic type of cell death by recombinant lactaptin analogues

    Troitskaya, O., Tkachenko, A., Kochneva, G., Richter, V. & Koval, O., Jul 2018, In: FEBS Open Bio. 8, p. 296-296 1 p.

    Research output: Contribution to journal › Meeting Abstract › peer-review

  8. Antimetastatic Effect of Liposomal Recombinant Lactaptin

    Kaledin, V. I., Koval, O. A., Kuligina, E. V., Lushnikova, E. L., Nikolin, V. P., Popova, N. A., Pyshnaya, I. A. & Richter, V. A., Apr 2018, In: Bulletin of Experimental Biology and Medicine. 164, 6, p. 762-765 4 p.

    Research output: Contribution to journal › Article › peer-review

  9. Analysis of in vitro activity of PSCA-specific CARs in the context of human NK cell line YT

    Matvienko, D. A., Kulemzin, S. V., Smagina, A. S., Belovezhets, T. N., Chikaev, A. N., Volkova, O. Y., Chikaev, N. A., Koval, O. A., Kuligina, E. V., Taranin, A. V. & Gorchakov, A. A., 1 Jan 2018, In: Cellular Therapy and Transplantation. 7, 2, p. 70-77 8 p.

    Research output: Contribution to journal › Article › peer-review

  10. Analysis of in vitro cytotoxicity of human nk cell line co-expressing a psma-specific car and an antitumor agent lactaptin

    Belovezhets, T. N., Matvienko, D. A., Volkova, O. Y., Koval, O. A., Tkachenko, A. V., Kuligina, E. V., Taranin, A. V. & Richter, V. A., 1 Jan 2018, In: Genes and Cells. 13, 3, p. 89-93 5 p.

    Research output: Contribution to journal › Article › peer-review

  11. 2017

  12. Immunogenicity of recombinant analog of antitumor protein lactaptin

    Tkachenko, A. V., Troitskaya, O. S., Semenov, D. V., Dmitrienko, E. V., Kuligina, E. V., Richter, V. A. & Koval, O. A., 9 Nov 2017, In: Molekuliarnaia biologiia. 51, 5, p. 787-796 10 p.

    Research output: Contribution to journal › Article › peer-review

  13. Immunogenicity of recombinant analog of antitumor protein lactaptin

    Tkachenko, A. V., Troitskaya, O. S., Semenov, D. V., Dmitrienko, E. V., Kuligina, E. V., Richter, V. A. & Koval, O. A., 1 Sept 2017, In: Molecular Biology. 51, 5, p. 687-694 8 p.

    Research output: Contribution to journal › Article › peer-review

Previous 1 2 3 4 5 6 Next

ID: 3445280